An acetylation site in the middle domain of Hsp90 regulates chaperone function

被引:355
作者
Scroggins, Bradley T.
Robzyk, Kenneth
Wang, Dongxia
Marcu, Monica G.
Tsutsumi, Shinji
Beebe, Kristin
Cotter, Robert J.
Felts, Sara
Toft, David
Karnitz, Larry
Rosen, Neal
Neckers, Len [1 ]
机构
[1] NCI, Urol Oncol Branch, Bethesda, MD 20892 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[5] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[6] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.molcel.2006.12.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heat-shock protein 90 (Hsp90) chaperones a key subset of signaling proteins and is necessary for malignant transformation. Hsp90 is subject to an array of posttranslational modifications that affect its function, including acetylation. Histone deacetylase (HDAC) inhibitors and knockdown of HDAC6 induce Hsp90 acetylation and inhibit its activity. However, direct determination of the functional consequences of Hsp90 acetylation has awaited mapping of specific sites. We now demonstrate that Hsp90 K294 is acetylated. Mutational analysis of K294 shows that its acetylation status is a strong determinant of client protein and cochaperone binding. In yeast, Hsp90 mutants that cannot be acetylated at K294 have reduced viability and chaperone function compared to WT or to mutants that mimic constitutive acetylation. These data suggest that acetylation/deacetylation of K294 plays an important role in regulating the Hsp90 chaperone cycle.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 36 条
[1]   Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex [J].
Ali, MMU ;
Roe, SM ;
Vaughan, CK ;
Meyer, P ;
Panaretou, B ;
Piper, PW ;
Prodromou, C ;
Pearl, LH .
NATURE, 2006, 440 (7087) :1013-1017
[2]   Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones [J].
Arlander, SJH ;
Felts, SJ ;
Wagner, JM ;
Stensgard, B ;
Toft, DO ;
Karnitz, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (05) :2989-2998
[3]   Activity of suberoylanilide hydroxamic acid against human breast cancer cells with amplification of Her-2 [J].
Bali, P ;
Pranpat, M ;
Swaby, R ;
Fiskus, W ;
Yamaguchi, H ;
Balasis, M ;
Rocha, K ;
Wang, HG ;
Richon, V ;
Bhalla, K .
CLINICAL CANCER RESEARCH, 2005, 11 (17) :6382-6389
[4]   Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90 - A novel basis for antileukemia activity of histone deacetylase inhibitors [J].
Bali, P ;
Pranpat, M ;
Bradner, J ;
Balasis, M ;
Fiskus, W ;
Guo, F ;
Rocha, K ;
Kumaraswamy, S ;
Boyapalle, S ;
Atadja, P ;
Seto, E ;
Bhalla, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (29) :26729-26734
[5]   Hsp90 inhibitors: Small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation [J].
Blagg, BSJ ;
Kerr, TA .
MEDICINAL RESEARCH REVIEWS, 2006, 26 (03) :310-338
[6]  
Blagosklonny MV, 2002, MOL CANCER THER, V1, P937
[7]   Dimerization and N-terminal domain proximity underlie the function of the molecular chaperone heat shock protein 90 [J].
Chadli, A ;
Bouhouche, I ;
Sullivan, W ;
Stensgard, B ;
McMahon, N ;
Catelli, MG ;
Toft, DO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12524-12529
[8]  
Furumai R, 2002, CANCER RES, V62, P4916
[9]   Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates [J].
Hartson, SD ;
Thulasiraman, V ;
Huang, WJ ;
Whitesell, L ;
Matts, RL .
BIOCHEMISTRY, 1999, 38 (12) :3837-3849
[10]   Structures of the N-terminal and middle domains of E-coli Hsp90 and conformation changes upon ADP binding [J].
Huai, Q ;
Wang, HC ;
Liu, YD ;
Kim, HY ;
Toft, D ;
Ke, HM .
STRUCTURE, 2005, 13 (04) :579-590